856250-30-1

Basic information

• Product Name: 2-benzyl-5-(4-chlorophenyl)-4-methoxypyridazin-3(2H)-one
• Synonyms: 2-benzyl-5-(4-chlorophenyl)-4-methoxypyridazin-3(2H)-one
• CAS NO: 856250-30-1
• Molecular Weight: 326.782
• Mol File: 856250-30-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-benzyl-5-(4-chlorophenyl)-4-methoxypyridazin-3(2H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-benzyl-5-(4-chlorophenyl)-4-methoxypyridazin-3(2H)-one(856250-30-1)
• EPA Substance Registry System: 2-benzyl-5-(4-chlorophenyl)-4-methoxypyridazin-3(2H)-one(856250-30-1)

Safety Data

• Hazardous Substances Data: 856250-30-1(Hazardous Substances Data)

Upstream product

• 637-87-6 1-Chloro-4-iodobenzene 
• 1679-18-1 4-Chlorophenylboronic acid 
• 77541-65-2 2-benzyl-5-chloro-4-methoxypyridazin-3(2H)-one 

Relevant articles and documents

Synthesis of (hetero)arylated pyridazin-3(2 H)-ones via Negishi reaction involving zincated pyridazin-3(2 H)-ones

Zincated pyridazin-3(2H)-ones generated via bromine - magnesium exchange followed by transmetalation using ZnCl2 or via lactam-directed ortho C4-H zincation with TMPZnCl·LiCl have been synthesized. These in situ created organometallics can be u

Azabicyclic heterocycles as cannabinoid receptor modulators

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, R6, R7, m and n are described herein.